This webinar is provided by National Jewish Health
This educational activity is supported by an educational grant from Insmed.
NTM is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM and new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, guideline-based treatment, personalized treatment selection for patients, and managing adverse events and improving patient adherence are discussed using video presentation of challenging cases.
Date and Time
This webinar will be held on six separate days
CME/CE credit provided